Results 151 to 160 of about 24,071 (243)

Impact of retinal thickness fluctuations with ranibizumab versus aflibercept in neovascular age-related macular degeneration (SALT): 12-month results from a multicentre, randomised, phase IV trial. [PDF]

Br J Ophthalmol
Agostini HT, Silva R, Holz FG, Larsen M, Altay L, Souied EH, Quiering C, Rose U, Liakopoulos S, SALT study group.   +9 more
europepmc   +1 more source

Early anatomical outcomes of faricimab vs aflibercept 2 mg in treatment-naïve neovascular age-related macular degeneration and polypoidal choroidal vasculopathy: A head-to-head comparative study in Taiwan. [PDF]

J Chin Med Assoc
Yang CC, Weng CC, Chou YB, Huang YM, Lin TC, Chen SJ, Hwang DK.   +6 more
europepmc   +1 more source

Treatment results switching from aflibercept to bevacizumab in wet age-related macular degeneration. [PDF]

Int J Ophthalmol
Kananen F.
europepmc   +1 more source

Impact of COVID-19 on a real-world treat-and-extend regimen with aflibercept for neovascular age-related macular degeneration [PDF]

Keean Nanji, Kevin Kennedy, Matthew Fung, Jim Shenchu Xie, Amin Hatamnejad, Sunir J. Garg, Charles C. Wykoff, Varun Chaudhary   +7 more
openalex   +1 more source

Role of Angiogenesis in Retinal Diseases and New Advances in Drug Development. [PDF]

Cells
Boey E, Zaidi H, Tang T, Yazdanyar A.
europepmc   +1 more source

Aflibercept exhibits VEGF binding stoichiometry distinct from bevacizumab and does not support formation of immune-like complexes [PDF]

, 2016

core   +1 more source

Safety and efficacy of AAV8-aflibercept in treating choroidal neovascularization via single-cell RNA sequencing. [PDF]

Mol Ther Methods Clin Dev
Shi J, Wu K, Chen L, Li Y, Jiang C.
europepmc   +1 more source

Comparative study on the efficacy of different aflibercept regimens in the treatment of macular edema secondary to branch retinal vein occlusion. [PDF]

Front Med (Lausanne)
Du X, Guo Y, Du M, Wang W, Liu M, Li S, Sheng Y.   +6 more
europepmc   +1 more source

Short-term outcomes of aflibercept therapy for diabetic macular edema in patients with incomplete response to ranibizumab and/or bevacizumab

, 2016
Raphaëlle Orès, Elise Philippakis, Pascale Massin, Ramin Tadayoni, Bénédicte Dupas   +4 more
openalex   +1 more source

Multiple Effects of Intravitreal Aflibercept on Microvascular Regression in Eyes with Diabetic Macular Edema

, 2019
Masahiko Sugimoto, Atushi Ichio, Daiki Mochida, Yumiho Tenma, Ryohei Miyata, Hisashi Matsubara, Mineo Kondo   +6 more
openalex   +1 more source